What Causes Hypertrophic Cardiomyopathy?

被引:31
作者
Maron, Bradley A. [1 ]
Wang, Rui-Sheng [2 ]
Carnethon, Mercedes R. [3 ]
Rowin, Ethan J. [4 ]
Loscalzo, Joseph [1 ]
Maron, Barry J. [4 ]
Maron, Martin S. [4 ]
机构
[1] Harvard Med Sch, Dept Med, Div Cardiovasc Med, Boston 02115, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[3] Feinberg Sch Med, Div Pulmonol & Crit Care, Chicago, IL USA
[4] Lahey Hosp & Med Ctr, HCM Ctr, Burlington, MA USA
关键词
CARDIAC-HYPERTROPHY; METABOLIC ABNORMALITIES; MYOCARDIAL FIBROSIS; MAGNETIC-RESONANCE; SYSTEMIC-SCLEROSIS; CLINICAL-COURSE; DISEASE; ASSOCIATION; SPECTROSCOPY; TACROLIMUS;
D O I
10.1016/j.amjcard.2022.06.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy (HCM) is a global and relatively common cause of patient morbidity and mortality and is among the first reported monogenic cardiac diseases. For 30 years, the basic etiology of HCM has been attributed largely to variants in individual genes encoding cardiac sarcomere proteins, with the implication that HCM is fundamen-tally a genetic disease. However, data from clinical and network medicine analyses, as well as contemporary genetic studies show that single gene variants do not fully explain the broad and diverse HCM clinical spectrum. These transformative advances place a new focus on possible novel interactions between acquired disease determinants and genetic context to produce complex HCM phenotypes, also offering a measure of caution against overemphasizing monogenics as the principal cause of this disease. These new perspectives in which HCM is not a uniformly genetic disease but likely explained by multifactorial eti-ology will also unavoidably impact how HCM is viewed by patients and families in the clin-ical practicing community going forward, including relevance to genetic counseling and access to healthcare insurance and psychosocial wellness. Published by Elsevier Inc.
引用
收藏
页码:74 / 82
页数:9
相关论文
共 86 条
[81]   Time to Think Differently About Sarcomere-Negative Hypertrophic Cardiomyopathy [J].
Watkins, Hugh .
CIRCULATION, 2021, 143 (25) :2415-2417
[82]   MECHANISMS OF DISEASE Inherited Cardiomyopathies [J].
Watkins, Hugh ;
Ashrafian, Houman ;
Redwood, Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (17) :1643-1656
[83]   Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy [J].
Wells, Sophie ;
Rowin, Ethan J. ;
Bhatt, Viraj ;
Maron, Martin S. ;
Maron, Barry J. .
CIRCULATION, 2018, 137 (18) :1973-1975
[84]   KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice [J].
Wong, Jasmine C. ;
Perez-Mancera, Pedro A. ;
Huang, Tannie Q. ;
Kim, Jangkyung ;
Grego-Bessa, Joaquim ;
Alzamora, Maria del Pilar ;
Kogan, Scott C. ;
Sharir, Amnon ;
Keefe, Susan H. ;
Morales, Carolina E. ;
Schanze, Denny ;
Castel, Pau ;
Hirose, Kentaro ;
Huang, Guo N. ;
Zenker, Martin ;
Sheppard, Dean ;
Klein, Ophir D. ;
Tuveson, David A. ;
Braun, Benjamin S. ;
Shannon, Kevin .
JCI INSIGHT, 2020, 5 (21)
[85]   MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation [J].
Wu, Xue ;
Simpson, Jeremy ;
Hong, Jenny H. ;
Kim, Kyoung-Han ;
Thavarajah, Nirusha K. ;
Backx, Peter H. ;
Neel, Benjamin G. ;
Araki, Toshiyuki .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (03) :1009-1025
[86]   Endothelial-to-mesenchymal transition contributes to cardiac fibrosis [J].
Zeisberg, Elisabeth M. ;
Tarnavski, Oleg ;
Zeisberg, Michael ;
Dorfman, Adam L. ;
McMullen, Julie R. ;
Gustafsson, Erika ;
Chandraker, Anil ;
Yuan, Xueli ;
Pu, William T. ;
Roberts, Anita B. ;
Neilson, Eric G. ;
Sayegh, Mohamed H. ;
Izumo, Seigo ;
Kalluri, Raghu .
NATURE MEDICINE, 2007, 13 (08) :952-961